PhD, Temple University, Philadelphia, PA, 2001
Terry Hyslop, PhD
Professor
Vice Chair, Department of Pharmacology, Physiology, & Cancer Biology
Director, Center for Cancer Health Equity
Contact Information
130 S. Ninth Street
Edison, Suite 1742
Philadelphia, PA 19107
Professor
Vice Chair, Department of Pharmacology, Physiology, & Cancer Biology
Director, Center for Cancer Health Equity
Education
Publications
- Genetic ancestry concordant RNA splicing in prostate cancer involves oncogenic genes and associates with recurrence
- Active Monitoring with or Without Endocrine Therapy for Low-Risk Ductal Carcinoma in Situ: The COMET Randomized Clinical Trial
- Patient-Reported Outcomes for Low-Risk Ductal Carcinoma in Situ: A Secondary Analysis of the COMET Randomized Clinical Trial
- Comparison of incident breast cancer cases in the largest national US tumor registries
- A latent class assessment of healthcare access factors and disparities in breast cancer care timeliness
Awards
- Fellow, American Statistical Association - 2016
- International Biometric Society ENAR Travel Award "Workshop for Junior Researchers" - 2002
- American Statistical Association Biopharmaceutical Section Best Student Paper Award - 2001
Research & Clinical Interests
My group works to develop novel modeling approaches that flexibly integrate social determinants of health with biomarkers and clinical data to further understand potential prevention strategies with a focus on minorities. I have Komen funding with Dr. Troester at UNC and Dr. Tomi Akinyemiju at Duke to study the integration of SDOH and biomarkers in metastatic breast cancer. I have Breast Cancer Research Foundation (BCRF) support to obtain long-term follow-up on patients in a Phase 3 study of DCIS and additional BCRF support for a health equity project focused on integrating SDOH and genomic markers. Finally, I have an Aim within an NCI study, partnering with Dr. Epplein from Duke, focused on developing a cells-to-society model of gastric cancer and H-pylori.
Biography
I am a Professor in the Department of Pharmacology, Physiology, and Cancer Biology, Director of the Sidney Kimmel Comprehensive Cancer Center for Health Equity, and co-Leader of the Cancer Risk and Control Program at the Jefferson Sidney Kimmel Comprehensive h-index of 70. I have been a PI, co-PI, or co-I of dozens of grants supported by NCI, Komen, the state of PA, and the Breast Cancer Research Foundation (BCRF). I serve as a reviewer for SPORE grants, for Cancer Center Support Grants (former NCI-A Parent Committee Permanent Member), P01s, U01s, U24s, Komen CCR, BCRF, ASCO/SU2C, DOD and numerous other mechanisms.